IT HAS BEEN suggested that radioresistant hypoxic cells may limit the success of radiotherapy in the local control of tumours (see recent review by Fowler, 1972) . We are investigating drugs which will preferentially radiosensitize such cells, one such drug being NDPP (p-nitro-3-dimethylaminopropiophenone hydrochloride) which has been shown in vitro to radiosensitize both bacterial and mammalian cells to give enhancement ratios (ER) of up to 4 3 and 2-6 respectively. The compound was synthesized from PNAP (p-nitroacetophenone) by a Mannich type condensation with formaldehyde and dimethylamine hydrochloride (by Roche Products Limited) and, whilst retaining the same phenone moiety as PNAP, NDPP had a greatly enhanced water solubility (Adams et al., 1972) . NDPP has also been shown to radiosensitize hypoxic murine skin in vivo to give enhancement ratios of 1P3 to 1.5 (Denekamp and Michael, 1972) .
The present work is concerned with the potential of NDPP to radiosensitize hypoxic cells within tumours. It has been performed in three parts. Initially NDPP was given to oxygen breathing mice but no conclusive enhancement was obtained, and therefore it was repeated using tumours which had been made artificially totally hypoxic. A small but positive enhancement was obtained. Rapid metabolism of the drug was suspected as a possible explanation for the poor result obtained in the first experiment, and so a third experiment was performed using high dose rate x-rays, in air breathing mice, in order to give the full x-ray dose within 17 min after injection of the NDPP.
MATERIALS AND METHODS
The tumours studied were first generation transplants of spontaneous mammary carcinomata occurring in the syngeneic C3H/He mice bred at the Gray Laboratory. This tumour has a volume doubling time of 6 days (range 3-12 days) from 8 mm to 10 mm mean diameter, and a proportion of about 10% of hypoxic cells (Fowler et al., unpublished (Potten and Howard, 1969) . Experiment 3: High dose rate and mice breathing air.-Five min after anaesthetizing mice were injected i.p. with 5 mg NDPP/ mouse. The x-irradiations commenced after a further 10 min and were performed on our linear electron accelerator modified to produce x-rays from 1-4 MeVp electrons on a thick gold target backed with 3 mm Cu. The distance from the target to the tumours was 26 cm. Dosimetry was done by Dr B. D. Michael using 2 Farmer-Baldwin dosimeters, one of 0-6 cm3 chamber volume with the voltage increased to 350 V and the axis parallel to the beam; the other of 0-2 cm3 volume with the axis perpendicular to the beam. Calibration was performed in a 60Co beam with an NPL calibrated chamber. The rad per roentgen factor was assumed to be 0 95. It is believed that the doses quoted are absolutely correct within 3 %. The dose rate was 900 rad min-', and build up material consisting of 0 6-1.0 mm of Perspex was placed over the tumour to ensure x-ray dose build up.
In Experiment 3 two analyses were performed: the proportion of tumours controlled after 150 days and the time required for recurrent tumours to reach a mean diameter of 8 mm.
RESULTS
After irradiation, tumours more than 6 mm diameter were classified as local recurrences, between 4 and 6 mm as ambiguous, and less than 4 mm as locally controlled. The tumours were measured weekly following irradiation. Mice with tumours of more than 8 mm mean diameter (i.e. clearly greater than 6 mm) were sacrificed, the others being kept for 150 days. Fowler et al. (1974) reported a sex dependent radiosensitivity with this tumour, and consequently both sexes have been analysed separately as shown in the Table. Significant differences were found in the present results. For determining enhancement ratios, the TCD50 was corrected to equal proportions of male and female mice. However, the conclusions remained the same even if only one sex was compared. The computer programme devised by Dr E. H. Porter of the Glasgow Institute of Radiotherapeutics and Dr L. J. Peters of the Gray Laboratory was used to calculate TCD50 and the standard error of this mean value, as described by Fowler et al. (1974) . Experiment 1 (Table and Fig. 1 both NDPP and x-rays. The incidence of metastases for mice with local recurrences were 5/21 and 1/10 respectively. Two of the mice receiving NDPP had grossly abnormal kidneys which were very small and fibrous.
Experiment 2 (Table and Fig. 2) The mice irradiated in air at 240 rad min-' with their tumours artificially made hypoxic had a TCD50 of 4275 rad with NDPP and x-rays, compared with 5075 rad for x-rays only, an ER of 1-19 ± 0-04 (s.e. mean). This corresponds to an improvement of local control from 50 to 83%, and is significantly different from no enhancement. There was again no significant diference in the development of metastases, the incidence of metastases in mice with controlled tumours being 4/51 for x-rayonly mice and 6/52 for mice receiving both NDPP and x-rays. The incidence of metastases for mice with local recurrences were 4/23 and 0/11 respectively.
Sixteen of the mice receiving NDPP had grossly abnormal kidneys at the time of death, although it was the cause of death in only 8 of these animals. Experiment 3 (Table and Fig. 3) The mice irradiated in air at 900 rad min-1 had a TCD50 of only 5126 rad with NDPP compared with 6416 rad for the controls, an ER of 1P25 i 0 05 (s.e. mean). This corresponds to an increase in local control from 50 to 93.0 NDPP again appeared to have no influence on the development of metastases, for in mice with locally controlled tumours 5/26 x-ray-only mice had metastases compared with 5/13 mice receiving both NDPP and x-rays. The incidence of metastaseA for mice with recurrent tumours was 16/71 and 16/44 respectively. Four mice receiving NDPP had grossly abnormal kidneys at time of death and 8 others had kidneys that were possibly smaller and paler than normal.
The average time taken for tumours to regrow to 8 mm mean diameter is shown in Fig. 4 . It was necessary to plot the average of the reciprocals of this time in each dose group, since many of the tumours were controlled and therefore required " infinite time " to regrow to 8 mm.
The 3000-rad dose group for mice receiving x-rays only appears anomalous, and if disregarded then enhancement ratios of about 1.2 5t0-05
nutrient broth with 20 mmol NDPP exhibited can enhancement ratio (ER) of 4 3, equivalent to that prodcuced by°2 itself, when irra(liated with 60%'o y rays (Adams et al., 1972 Whatever the reason for the lack of radiosensitization in the first experiment, the more important result is thought to be the significant radiosensitization obtained in the second and third experiment.
The disparity between the enhancement ratios obtained from the in vivo and in vitro studies remains. In vitro work in broth has shown a decreased effectiveness of NDPP compared with that in buffered saline, and it has been suggested that the compound binds with protein (Watts et al., unpublished) . In vivo both protein binding and rapid metabolism have been shown to reduce the effectiveness of NDPP (Whitmore et al., 1973) , which probably explains why a maximum ER of only 1 25 was obtained in the present and other work in vivo (Denekamp and Michael, 1972) compared with the ER of 1P7 for mammalian cells in vitro (Asquith, unpublished) .
At the concentrations used in this work, NDPP showed no evidence of increasing the frequency of metastases but did cause toxicological problems resulting in an appreciably higher premature death rate (Table) . This was due mainly to both a cumulative action with anaesthetic on depression of respiration at time of irradiation and, in the longer term, by causing macroscopic changes in kidney structure.
In summary, although NDPP radiosensitizes well in vitro, it does so only poorly in vivo at concentrations demonstrating appreciable toxicity. Radiosensitizers such as metronidazole (Begg, Sheldon and Foster, 1974) and a 2-nitroimidazole Ro-07-0582 give better enhancement ratios for lower toxicity.
